Jongh, F.E. de

patient cisplatin cancer 0.00 study treatment -01 pharmacokinetic paclitaxel toxicity administration tumor breast platinum hsa-mir plasma chemotherapy analysis totaal clearance regimen concentration tamoxifen pagina 27-08-2003 verweij j range thyroid level group infusion mirna 0.01 grade sample value table disease model expression chapter dextromethorphan combination month population cycle verweij phase creatinine schedule oncol variability effect cluster -02 stoter g factor neurotoxicity cisplatin infusion endoxifen parameter breast cancer nephrotoxicity creatinine clearance cisplatine result chloride hypertonic saline number high-dose cisplatin response survival serum transcript etoposide saline association cyp 2d jonge mja plasma chloride concentration